The Ohio State University Investigational Drug Services — Columbus, Ohio

The Ohio State University Investigational Drug Services is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

The Ohio State University Investigational Drug Services has participated in 6 clinical trials.

Therapeutic areas: Anemia, Sickle Cell, Carcinoma, Non-Small-Cell Lung, Non Small Cell Lung Cancer ALK Positive or ROS1 Positive.

Sponsors: Biossil Inc., Pfizer, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Ohio State University Investigational Drug Services?

The Ohio State University Investigational Drug Services has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Ohio State University Investigational Drug Services conducted?

The Ohio State University Investigational Drug Services has 6 clinical trials on record. Their work covers Anemia, Sickle Cell, Carcinoma, Non-Small-Cell Lung, Non Small Cell Lung Cancer ALK Positive or ROS1 Positive.

Is The Ohio State University Investigational Drug Services accredited by Crixeo Health?

Yes — The Ohio State University Investigational Drug Services holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Ohio State University Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.